Digital health start-up Amalgam Rx launched today with the release of iSage Rx, which it touts as the 1st FDA 510(k)-cleared, prescription mobile app for insulin titration.
The app allows physicians to choose from clinically-validated basal insulin algorithms and tailor them to the needs of their patients with Type II diabetes. Patients record their blood glucose levels and if their levels are not under control, the app can suggest an increase in insulin based on their doctor’s recommendation.
Get the full story at our sister site, Drug Delivery Business News.
The post Digital health start-up Amalgam Rx launches with insulin titration app appeared first on MassDevice.